Changing dynamics of bloodstream infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium in Germany, 2017-2023: a continued burden of disease approach

被引:1
|
作者
Brinkwirth, Simon [1 ,2 ,3 ]
Feig, Marcel [4 ]
Noll, Ines [1 ]
Eckmanns, Tim [1 ]
Doerre, Achim [1 ,2 ]
Haller, Sebastian [1 ]
Willrich, Niklas [1 ]
机构
[1] Robert Koch Inst, Dept Infect Dis Epidemiol, Healthcare Associated Infect Surveillance Antibiot, See Str 10, D-13353 Berlin, Germany
[2] Robert Koch Inst, Dept Infect Dis Epidemiol, Postgrad Training Appl Epidemiol PAE, See Str 10, D-13353 Berlin, Germany
[3] European Ctr Dis Prevent & Control ECDC, ECDC Fellowship Programme, Field Epidemiol Path EPIET, Stockholm, Sweden
[4] Robert Koch Inst, Unit MF2 Domain Spec Data Competence Ctr, Dept Methods Dev Res Infrastruct & Informat Techno, See Str 10, D-13353 Berlin, Germany
来源
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL | 2025年 / 14卷 / 01期
关键词
GENDER-DIFFERENCES; EPIDEMIOLOGY; CARRIAGE;
D O I
10.1186/s13756-025-01522-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundAntimicrobial resistance is a global threat to public health, with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREfm) being major contributors. Despite their clinical impact, comprehensive assessments of changes of the burden of bloodstream infections in terms of Disability-Adjusted Life Years (DALYs) and attributable deaths over time are lacking, particularly in Germany.MethodsWe used data from the Antimicrobial Resistance Surveillance system, which covered about 30% of German hospitals. Bloodstream infections were defined by a VREfm or MRSA-positive blood culture. We estimated incidences as a first step to further use these rates to calculate DALYs and attributable deaths using the Burden of Communicable Disease in Europe toolkit. The analysis included stratification by age, sex and region.ResultsFrom 2017 to 2023, 6262 MRSA and 5442 VREfm blood culture-positive isolates were identified. The incidence of MRSA bloodstream infections decreased from 4.0 to 2.1 per 100,000 population, with estimated DALYs decreasing from 14.6 to 8.6 per 100,000 and attributable deaths from 591 to 316. Conversely, VREfm-BSI incidence doubled from 1.7 to a peak of 3.0 (2021) before declining back to 1.7 per 100,000 in 2023, with estimated DALYs increasing from 8.9 to 16.5 and then decreasing to 8.5 per 100,000 and attributable deaths increasing from 317 to 327. Men and people over 60 years had the highest burden, with noticeable regional differences.ConclusionMRSA and VREfm bloodstream infections followed different trends in the past and now present a comparable burden in Germany. Both pathogens pose a significant threat, particularly to hospitalised older aged men. Our findings highlight the need for targeted prevention and continued surveillance of MRSA and VREfm to reduce infections and their impact.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) Flags on Hospital Operations
    Shenoy, Erica S.
    Lee, Hang
    Hou, Taige
    Ware, Winston
    Ryan, Erin E.
    Hooper, David C.
    Walensky, Rochelle P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (07): : 782 - 790
  • [32] Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile
    Johnston, B. Lynn
    Bryce, Elizabeth
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (06) : 627 - 631
  • [33] Survival of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus spp. for an Extended Period of Transport
    Robinson, Gwen L.
    Harris, Anthony D.
    Morgan, Daniel J.
    Pineles, Lisa
    Belton, Beverly M.
    Johnson, J. Kristie
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (07) : 2466 - 2468
  • [34] Improving Efficiency in Active Surveillance for Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococcus at Hospital Admission
    Morgan, Daniel J.
    Day, Hannah R.
    Furuno, Jon P.
    Young, Atlisa
    Johnson, J. Kristie
    Bradham, Douglas D.
    Perencevich, Eli N.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (12): : 1230 - 1235
  • [35] METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND VANCOMYCIN-RESISTANT ENTEROCOCCUS CARRIAGE RATES IN A NEONATAL INTENSIVE CARE UNIT
    Saygan, Sibel Bakir
    Yasar, Handan
    Eras, Zeynep
    Cesur, Salih
    Irmak, Hasan
    Dilmen, Ugur
    Demiroz, Ali Pekcan
    MIKROBIYOLOJI BULTENI, 2010, 44 (03): : 529 - 531
  • [36] Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus
    Shetty, N
    Wilson, APR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) : 633 - 637
  • [37] Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections was selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control
    Schentag, JJ
    Hyatt, JM
    Carr, JR
    Paladino, JA
    Birmingham, MC
    Zimmer, GS
    Cumbo, TJ
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) : 1204 - 1214
  • [38] Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
    Miro-Canturri, Andrea
    Vila-Dominguez, Andrea
    Caretero-Ledesma, Marta
    Ayerbe-Algaba, Rafael
    Pachon, Jeronimo
    Enrique Jimenez-Mejias, Manuel
    Smani, Younes
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [39] Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation
    Hayakawa, K.
    Marchaim, D.
    Bathina, P.
    Martin, E. T.
    Pogue, J. M.
    Sunkara, B.
    Kamatam, S.
    Ho, K.
    Willis, L. B.
    Ajamoughli, M.
    Patel, D.
    Khan, A.
    Lee, K. P.
    Suhrawardy, U.
    Jagadeesh, K. K.
    Reddy, S. M. L.
    Levine, M.
    Ahmed, F.
    Omotola, A. M.
    Mustapha, M.
    Moshos, J. A.
    Rybak, M. J.
    Kaye, K. S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (06) : 815 - 820
  • [40] Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation
    K. Hayakawa
    D. Marchaim
    P. Bathina
    E. T. Martin
    J. M. Pogue
    B. Sunkara
    S. Kamatam
    K. Ho
    L. B. Willis
    M. Ajamoughli
    D. Patel
    A. Khan
    K. P. Lee
    U. Suhrawardy
    K. K. Jagadeesh
    S. M. L. Reddy
    M. Levine
    F. Ahmed
    A. M. Omotola
    M. Mustapha
    J. A. Moshos
    M. J. Rybak
    K. S. Kaye
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 815 - 820